Protein/ Hormone Based Nanoparticles as Carriers for Drugs Targeting Protein-Protein Interactions-Reference-Cited by-同舟云学术

Protein/ Hormone Based Nanoparticles as Carriers for Drugs Targeting Protein-Protein Interactions

Published:2019-05-02 Issue:6 Volume:19 Page:444-456
ISSN:1568-0266
Container-title:Current Topics in Medicinal Chemistry
language:en
Short-container-title:CTMC

Author:

Al-Suhaimi Ebtesam¹,Ravinayagam Vijaya²,Jermy B. Rabindran³,Mohamad Tarhini⁴,Elaissari Abdelhamid⁴

Affiliation:

1. Biology Department, College of Science, Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi Arabia

2. Deanship of Scientific Research & Nanomedicine Research Department, Institute of Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi Arabia

3. Nanomedicine Research Department, Institute of Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi Arabia

4. University Lyon, University Claude Bernard Lyon-1, CNRS, LAGEP-UMR 5007, F- 69622 Lyon, France

Abstract

Background: In this review, protein-protein interactions (PPIs) were defined, and their behaviors in normal in disease conditions are discussed. Their status at nuclear, molecular and cellular level was underscored, as for their interference in many diseases. Finally, the use of protein nanoscale structures as possible carriers for drugs targeting PPIs was highlighted. Objective: The objective of this review is to suggest a novel approach for targeting PPIs. By using protein nanospheres and nanocapsules, a promising field of study can be emerged. Methods: To solidify this argument, PPIs and their biological significance was discussed, same as their role in hormone signaling. Results: We shed the light on the drugs that targets PPI and we suggested the use of nanovectors to encapsulate these drugs to possibly achieve better results. Conclusion: Protein based nanoparticles, due to their advantages, can be suitable carriers for drugs targeting PPIs. This can open a new opportunity in the emerging field of multifunctional therapeutics.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

Reference85 articles.

1. Iegre J, Ahmed NS, Gaynord JS, Wu Y, Herlihy KM, Tan YS, Lopes-Pires ME, Jha R, Lau YH, Sore HF, Verma C, O’ Donovan DH, Pugh N, Spring DR. Chem Sci (Camb), Stapled peptides as a new technology to investigate protein-protein interactions in human platelets.,, 2018, 9, 4638-4643,10.1039/C8/SC00284C

2. Bakail M, Ochsenbein F. C R Chim, Targeting protein–protein interactions, A wide open field for drug design.,, 2016, 19, 19-27,10.1016/j.crci.2015.12.004

3. Yin H, Hamilton AD. Angew Chem Int Ed Engl, Strategies for targeting protein-protein interactions with synthetic agents.,, 2005, 44, 4130-4163,10.1002/anie.200461786

4. Tarhini M, Greige-Gerges H, Elaissari A. Int J Pharm, Protein-based nanoparticles: From preparation to encapsulation of active molecules.,, 2017, 522, 172-197,10.1016/j.ijpharm.2017.01.067

5. Shibue R, Sasamoto T, Shimada M, Zhang B, Yamagishi A, Akanuma S. Sci Rep, Comprehensive reduction of amino acid set in a protein suggests the importance of prebiotic amino acids for stable proteins.,, 2018, 8, 1227-,10.1038/s41598-018-19561-1

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of melatonin-loaded, human-serum-albumin nanoparticles formulations using different methods of preparation for ophthalmic administration;International Journal of Pharmaceutics;2022-11

2. Design and Development of Drugs Targeting Protein-Protein Interactions – Part-I;Current Topics in Medicinal Chemistry;2019-05-02